Explore Our Comprehensive Pharmaceuticals Industry Research Reports
U
2025
Zoledronic acid is a bisphosphonate drug, which reduces bone loss and treats bone complications such as low bone density. This acid is majorly used for the treatment of ...
Report Code : A03027 | Category : Life Sciences
P
2022
The Gynecological Cancer Drugs Market was valued at $11.6 billion in 2020 and is projected to reach $21.8 billion by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A03071 | Pages : 190 | Category : Life Sciences
U
2025
Herceptin, also known as trastuzumab, is used as a medication for patients who suffer from cancer, which assists in controlling the growth and spread of cancer cells in ...
Report Code : A03075 | Category : Life Sciences
P
2018
Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy ...
Report Code : A03078 | Pages : 197 | Category : Life Sciences
U
2025
Progesterone is the naturally occurring steroid hormone that is produced in adrenal glands, ovary, and placenta (during pregnancy). Progesterone is mainly involved in the maintenance of pregnancy, regulation ...
Report Code : A03080 | Category : Life Sciences
U
2025
Exeter erlotinib hydrochloride tablets are medications indicated for cancer diseases. Exeter erlotinib hydrochloride tablets aids by blocking the tyrosine kinase receptor, which further acts on the epidermal growth ...
Report Code : A03130 | Category : Life Sciences
U
2025
Glycosylated peptide are used as a mediators of key biological function with unique intrinsic properties with potential to treat variety of diseases. Glycosylation of peptide drugs benefits with ...
Report Code : A03131 | Category : Life Sciences
U
2025
Granulocyte-colony stimulating factor (G-CSF) is glycoprotein that stimulates the bone marrow to produce stem cells and granulocytes & release it into the bloodstream. G-CSF is produced by different ...
Report Code : A03132 | Category : Life Sciences
U
2025
Hemodialysis powder solution is mainly used to remove waste materials from the blood and retain useful components from leaving the blood. It is also used to correct acid-base and electrolyte imbalance during chronic renal failure.
Report Code : A03136 | Category : Life Sciences
U
2025
Herbal medicines are a type of dietary supplements extracted from different parts of the plant such as leaves, bark, seeds, berries, and roots. Herbal medicines are available in various dosage forms such as tablets, extracts, dried plants, and others.
Report Code : A03138 | Category : Life Sciences
U
2025
A placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange through the mothers blood ...
Report Code : A03139 | Category : Life Sciences
U
2025
Hydroxyzine imine are medications which are intended for an organic disease state when it manifests through anxiety. Hydroxyzine imine is a drug that attenuates activity in the central ...
Report Code : A03140 | Category : Life Sciences
U
2025
Montelukast sodium is a leukotriene inhibitory agent that is used for many indications that includes asthma, exercise induced bronchospasm, allergic rhinitis, primary dysmenorrhea and urticaria. It is generally ...
Report Code : A03142 | Category : Life Sciences
U
2025
Raloxifene hydrochloride is an oral medication intended for the prevention of osteoporosis in postmenopausal women. In addition, raloxifene hydrochloride medications are also used for the reduction of risk ...
Report Code : A03143 | Category : Life Sciences
P
2020
The global colposcopes market size was valued at $470 million in 2018, and is projected to reach $661 million by 2026, registering a CAGR of 4.3%.
Report Code : A03149 | Pages : 210 | Category : Life Sciences
P
2022
The global vegetarian softgel capsules market size was valued at $527.28 million in 2020 and is projected to reach $824.39 million by 2030 registering a CAGR of 4.6% ...
Report Code : A03164 | Pages : 210 | Category : Life Sciences
P
2020
The global cephalosporin market size was valued at $13.69 billion in 2019, and is estimated to reach $16.87 million by 2027, growing at a CAGR of 2.6% from 2019 to 2027.
Report Code : A03170 | Pages : 266 | Category : Life Sciences
U
2025
Esmolol is a class II antiarrhythmic drug used to prevent and treat tachycardia and acute supraventricular tachycardia. Esmolol hydrochlorlde injection is used for the short-term treatment of tachycardia and hypertension during surgery.Â
Report Code : A03172 | Category : Life Sciences
U
2022
Dendritic cells (DCs) refer to rare kinds of leukocytes. They are used in therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to ...
Report Code : A03179 | Category : Life Sciences
U
2025
Swine health is associated with the diseases caused due to pigs and the development of therapeutics to prevent the related ailments and disorders. Pig breeding can lead to ...
Report Code : A03181 | Category : Life Sciences
U
2025
Gastrointestinal diseases include complications related to the stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver, and pancreas. Gastrointestinal over the counter (OTC) drugs are medications that can be bought without any doctor™s prescription and are used to control vomiting, constipation, diarrhea, and flatulence.Â
Report Code : A03191 | Category : Life Sciences
P
2023
The global gastrointestinal therapeutics market was valued at $39.5 billion in 2022, and is projected to reach $64.5 billion by 2032, growing at a CAGR of 5% from 2023 to 2032.
Report Code : A03195 | Pages : 320 | Category : Life Sciences
U
2025
Allergic rhinitis is an allergic response to specific allergens. An allergen is an otherwise harmless substance that has the ability to cause an allergic reaction in conducive conditions. ...
Report Code : A03200 | Category : Life Sciences
P
2018
The global allergy treatment market was valued at $24,653.4 million in 2017 and is expected to reach $40,360.2 million by 2025, registering a CAGR of 6.3% from 2018 to 2025
Report Code : A03201 | Pages : 220 | Category : Life Sciences
P
2022
The global diabetes therapeutics market was valued at $118,063.3 million in 2020 and is projected to reach $317,915 million by 2030, growing at a CAGR of 10.4% from ...
Report Code : A03202 | Pages : 160 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.